Gates Scholar’s contribution to diabetes research

  • June 28, 2010

A Gates Scholar is a joint first author of a new paper on the effects of diabetes, published in The Lancet.

The article, published in this week’s issue of The Lancet, shows that diabetes approximately doubles the risk of a wide range of blood vessel diseases, including heart attacks and different types of stroke.

The research is based on an analyisis of 700,000 people, each of whom was monitored for about a decade in 102 surveys conducted in 25 countries. The analysis was made by an international consortium led by Cambridge’s Dr Nadeem Sarwar and Professor John Danesh in the Cardiovascular Epidemiology Unit.

Rao Kondapally Seshasai is a joint first author of this research, which will also be presented at the American Diabetes Association’s 70th Scientific Sessions in Orlando, Florida.

Rao features also this week, alongside Gates Scholar Sebhat Erqou, in research published in the Archives of Internal Medicine on the use of statins. Contrary to previous reports based on more limited data, the research has found that short-term use of statins in patients without a history of heart attacks and strokes has only a borderline effect.

Latest News

2026 US Scholars announced

Twenty-six of the most academically brilliant social leaders in the US have been selected to be part of the 2026 class of Gates Cambridge Scholars at the University of Cambridge. […]

Advocating for gender minorities worldwide

Muaz Chaudhry is proud to have carved his own path, defying social expectations and norms to do impactful research in the field of gender economics and to lead an NGO, […]

Scholar contributes to international AI safety report

A Gates Cambridge Scholar is a contributor to the new International AI Safety Report 2026, the most comprehensive evidence-based assessment of AI capabilities, emerging risks and safety measures to date. […]

Top health innovation role for Gates Cambridge Scholar

Gates Cambridge Scholar Lina Scroggins has been appointed chief product officer at leading US health firm Mercy. Lina [2005], who did her MPhil in Biological Science, has been working for […]